234 related articles for article (PubMed ID: 20331478)
1. Assessing the immunopotency of Toll-like receptor agonists in an in vitro tissue-engineered immunological model.
Ma Y; Poisson L; Sanchez-Schmitz G; Pawar S; Qu C; Randolph GJ; Warren WL; Mishkin EM; Higbee RG
Immunology; 2010 Jul; 130(3):374-87. PubMed ID: 20331478
[TBL] [Abstract][Full Text] [Related]
2. Monocyte-derived DC primed with TLR agonists secrete IL-12p70 in a CD40-dependent manner under hyperthermic conditions.
Peng JC; Hyde C; Pai S; O'Sullivan BJ; Nielsen LK; Thomas R
J Immunother; 2006; 29(6):606-15. PubMed ID: 17063123
[TBL] [Abstract][Full Text] [Related]
3. Toll-like receptor ligands modulate dendritic cells to augment cytomegalovirus- and HIV-1-specific T cell responses.
Loré K; Betts MR; Brenchley JM; Kuruppu J; Khojasteh S; Perfetto S; Roederer M; Seder RA; Koup RA
J Immunol; 2003 Oct; 171(8):4320-8. PubMed ID: 14530357
[TBL] [Abstract][Full Text] [Related]
4. Intravenous immunoglobulin modulates the maturation of TLR 4-primed peripheral blood monocytes.
Ballow M; Allen C
Clin Immunol; 2011 May; 139(2):208-14. PubMed ID: 21406333
[TBL] [Abstract][Full Text] [Related]
5. Toll like receptor agonists augment HPV 11 E7-specific T cell responses by modulating monocyte-derived dendritic cells.
Chen XZ; Mao XH; Zhu KJ; Jin N; Ye J; Cen JP; Zhou Q; Cheng H
Arch Dermatol Res; 2010 Jan; 302(1):57-65. PubMed ID: 19578865
[TBL] [Abstract][Full Text] [Related]
6. Combined Toll-like receptor agonists synergistically increase production of inflammatory cytokines in human neonatal dendritic cells.
Krumbiegel D; Zepp F; Meyer CU
Hum Immunol; 2007 Oct; 68(10):813-22. PubMed ID: 17961769
[TBL] [Abstract][Full Text] [Related]
7. Bacterial CpG-DNA triggers activation and maturation of human CD11c-, CD123+ dendritic cells.
Bauer M; Redecke V; Ellwart JW; Scherer B; Kremer JP; Wagner H; Lipford GB
J Immunol; 2001 Apr; 166(8):5000-7. PubMed ID: 11290780
[TBL] [Abstract][Full Text] [Related]
8. Antigen presentation and immune regulatory capacity of immature and mature-enriched antigen presenting (dendritic) cells derived from human bone marrow.
Jin Y; Fuller L; Ciancio G; Burke GW; Tzakis AG; Ricordi C; Miller J; Esquenzai V
Hum Immunol; 2004 Feb; 65(2):93-103. PubMed ID: 14969764
[TBL] [Abstract][Full Text] [Related]
9. Synergy between vitamin D(3) and Toll-like receptor agonists regulates human dendritic cell response during maturation.
Brosbøl-Ravnborg A; Bundgaard B; Höllsberg P
Clin Dev Immunol; 2013; 2013():807971. PubMed ID: 23710204
[TBL] [Abstract][Full Text] [Related]
10. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides.
Hornung V; Rothenfusser S; Britsch S; Krug A; Jahrsdörfer B; Giese T; Endres S; Hartmann G
J Immunol; 2002 May; 168(9):4531-7. PubMed ID: 11970999
[TBL] [Abstract][Full Text] [Related]
11. Role of the cytokine environment and cytokine receptor expression on the generation of functionally distinct dendritic cells from human monocytes.
Conti L; Cardone M; Varano B; Puddu P; Belardelli F; Gessani S
Eur J Immunol; 2008 Mar; 38(3):750-62. PubMed ID: 18236400
[TBL] [Abstract][Full Text] [Related]
12. Activation of Toll-Like Receptors Differentially Modulates Inflammation in the Human Reproductive Tract: Preliminary Findings.
Benjelloun F; Quillay H; Cannou C; Marlin R; Madec Y; Fernandez H; Chrétien F; Le Grand R; Barré-Sinoussi F; Nugeyre MT; Menu E
Front Immunol; 2020; 11():1655. PubMed ID: 32849571
[TBL] [Abstract][Full Text] [Related]
13. PD-L1 expression on tolerogenic APCs is controlled by STAT-3.
Wölfle SJ; Strebovsky J; Bartz H; Sähr A; Arnold C; Kaiser C; Dalpke AH; Heeg K
Eur J Immunol; 2011 Feb; 41(2):413-24. PubMed ID: 21268011
[TBL] [Abstract][Full Text] [Related]
14. Cyclic nucleotides promote monocyte differentiation toward a DC-SIGN+ (CD209) intermediate cell and impair differentiation into dendritic cells.
Giordano D; Magaletti DM; Clark EA; Beavo JA
J Immunol; 2003 Dec; 171(12):6421-30. PubMed ID: 14662841
[TBL] [Abstract][Full Text] [Related]
15. Synergistic effect of Nod1 and Nod2 agonists with toll-like receptor agonists on human dendritic cells to generate interleukin-12 and T helper type 1 cells.
Tada H; Aiba S; Shibata K; Ohteki T; Takada H
Infect Immun; 2005 Dec; 73(12):7967-76. PubMed ID: 16299289
[TBL] [Abstract][Full Text] [Related]
16. The TLR-specific adjuvants R-848 and CpG-B endorse the immunological reaction of neonatal antigen-presenting cells.
Schüller S; Wisgrill L; Sadeghi K; Gindl E; Helmer H; Husslein P; Berger A; Spittler A; Förster-Waldl E
Pediatr Res; 2016 Aug; 80(2):311-8. PubMed ID: 27057737
[TBL] [Abstract][Full Text] [Related]
17. Plasmacytoid dendritic cells produce cytokines and mature in response to the TLR7 agonists, imiquimod and resiquimod.
Gibson SJ; Lindh JM; Riter TR; Gleason RM; Rogers LM; Fuller AE; Oesterich JL; Gorden KB; Qiu X; McKane SW; Noelle RJ; Miller RL; Kedl RM; Fitzgerald-Bocarsly P; Tomai MA; Vasilakos JP
Cell Immunol; 2002; 218(1-2):74-86. PubMed ID: 12470615
[TBL] [Abstract][Full Text] [Related]
18. The influence of CD40 ligation and interferon-gamma on functional properties of human monocyte-derived dendritic cells activated with polyinosinic-polycytidylic acid.
Dragicević A; Dzopalić T; Vasilijić S; Vucević D; Bozić B; Majstorović I; Balint B; Colić M
Vojnosanit Pregl; 2011 Apr; 68(4):301-8. PubMed ID: 21627015
[TBL] [Abstract][Full Text] [Related]
19. CpG-A oligonucleotides induce a monocyte-derived dendritic cell-like phenotype that preferentially activates CD8 T cells.
Krug A; Rothenfusser S; Selinger S; Bock C; Kerkmann M; Battiany J; Sarris A; Giese T; Speiser D; Endres S; Hartmann G
J Immunol; 2003 Apr; 170(7):3468-77. PubMed ID: 12646607
[TBL] [Abstract][Full Text] [Related]
20. Dendritic Cells Generated in the Presence of Platelet Lysate Have a Reduced Type 1 Polarization Capacity.
Tešić N; Pekle Simonič I; Roškar K; Rožman P; Švajger U
Immunol Invest; 2020 Apr; 49(3):215-231. PubMed ID: 31170833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
